ALLE vs MBX · P/E 21, rev $2.19B vs $1.98B cap
Allegion PLC (ALLE) versus MBX Biosciences, Inc. Common Stock (MBX) — a side-by-side from cached financials, not a winner call.
Allegion PLC (ALLE) is a security & protection services company listed on US.
MBX Biosciences, Inc. Common Stock (MBX) is a biotechnology company listed on NASDAQ.
Latest reported ALLE revenue for 2026-06-30 was $2.19B. Net income was $322.7M. ALLE currently screens at market cap $12.71B and trailing P/E 20.7.
MBX does not have a complete income-statement cache yet.
ALLE currently screens at market cap $12.71B and trailing P/E 20.7. MBX currently screens at market cap $1.98B.
Not investment advice. Open the ALLE and MBX stock pages for the full models.
Not investment advice.